Brief reports

78Citations
Citations of this article
358Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Phenelzine was administered to 11 patients meeting DSM-III criteria for social phobia in open clinical trials. Seven of 11 showed marked improvement, while the remaining four experienced moderate benefit. These findings, which require replication in controlled trials, suggest that in addition to other actions, phenelzine has a direct effect in reducing interpersonal hypersensitivity. © 1986 by Williams and Wilkins Co.

References Powered by Scopus

Six-Month Prevalence of Psychiatric Disorders in Three Communities: 1980 to 1982

1305Citations
N/AReaders
Get full text

Treatment of Endogenous Anxiety with Phobic, Hysterical, and Hypochondriacal Symptoms

606Citations
N/AReaders
Get full text

Social Phobia: Review of a Neglected Anxiety Disorder

485Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Phenelzine vs atenolol in social phobia - A placebo-controlled comparison

429Citations
N/AReaders
Get full text

Antidepressant Specificity in Atypical Depression

321Citations
N/AReaders
Get full text

Treatment of social phobia with clonazepam and placebo

292Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liebowitz, M. R., Fyer, A. J., Gorman, J. M., Campeas, R., & Levin, A. (1986). Brief reports. Journal of Clinical Psychopharmacology, 6(2), 93–98. https://doi.org/10.4324/9781003093763-19

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 182

65%

Researcher 53

19%

Professor / Associate Prof. 34

12%

Lecturer / Post doc 13

5%

Readers' Discipline

Tooltip

Psychology 144

62%

Medicine and Dentistry 44

19%

Agricultural and Biological Sciences 27

12%

Social Sciences 17

7%

Save time finding and organizing research with Mendeley

Sign up for free